Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13511 | 768 | 47.5 | 94% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
313 | 17635 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEDD9 | Author keyword | 50 | 81% | 4% | 30 |
2 | HEF1 | Author keyword | 32 | 80% | 3% | 20 |
3 | CRK | Author keyword | 32 | 48% | 6% | 49 |
4 | CRKL | Author keyword | 30 | 51% | 5% | 42 |
5 | DOCK180 | Author keyword | 26 | 68% | 3% | 23 |
6 | C3G | Author keyword | 24 | 59% | 4% | 27 |
7 | P130CAS | Author keyword | 20 | 38% | 5% | 42 |
8 | V CRK | Author keyword | 18 | 89% | 1% | 8 |
9 | BCAR3 | Author keyword | 15 | 88% | 1% | 7 |
10 | BCAR1 | Author keyword | 14 | 100% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEDD9 | 50 | 81% | 4% | 30 | Search NEDD9 | Search NEDD9 |
2 | HEF1 | 32 | 80% | 3% | 20 | Search HEF1 | Search HEF1 |
3 | CRK | 32 | 48% | 6% | 49 | Search CRK | Search CRK |
4 | CRKL | 30 | 51% | 5% | 42 | Search CRKL | Search CRKL |
5 | DOCK180 | 26 | 68% | 3% | 23 | Search DOCK180 | Search DOCK180 |
6 | C3G | 24 | 59% | 4% | 27 | Search C3G | Search C3G |
7 | P130CAS | 20 | 38% | 5% | 42 | Search P130CAS | Search P130CAS |
8 | V CRK | 18 | 89% | 1% | 8 | Search V+CRK | Search V+CRK |
9 | BCAR3 | 15 | 88% | 1% | 7 | Search BCAR3 | Search BCAR3 |
10 | BCAR1 | 14 | 100% | 1% | 7 | Search BCAR1 | Search BCAR1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | V CRK | 85 | 59% | 12% | 95 |
2 | HEF1 | 65 | 93% | 3% | 25 |
3 | P130CAS | 41 | 41% | 10% | 79 |
4 | CAS L | 41 | 85% | 3% | 22 |
5 | C CRK | 40 | 71% | 4% | 32 |
6 | MYOBLAST CITY | 28 | 64% | 4% | 28 |
7 | SUBSTRATE LYMPHOCYTE TYPE | 26 | 100% | 1% | 11 |
8 | ADAPTER PROTEIN CAS | 23 | 79% | 2% | 15 |
9 | CRK | 22 | 40% | 6% | 44 |
10 | DOCKING PROTEIN HEF1 | 22 | 81% | 2% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases | 2015 | 1 | 111 | 72% |
GEF what? Dock 180 and related proteins help Rac to polarize cells in new ways | 2007 | 135 | 49 | 57% |
Integrin signalling adaptors: not only figurants in the cancer story | 2010 | 122 | 151 | 31% |
Crk and CrkL adaptor proteins: networks for physiological and pathological signaling | 2009 | 78 | 201 | 49% |
CAS proteins in normal and pathological cell growth control | 2010 | 59 | 235 | 49% |
p130Cas: a versatile scaffold in signaling networks | 2006 | 171 | 87 | 46% |
Insights into the biological functions of Dock family guanine nucleotide exchange factors | 2014 | 12 | 94 | 36% |
CAS Proteins in Health and Disease: An Update | 2014 | 3 | 77 | 66% |
Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold | 2004 | 106 | 153 | 45% |
Integrin signalling: a new Cas(t) of characters enters the stage | 2000 | 213 | 78 | 47% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MICROORGANISMS IMMUNIZAT | 3 | 100% | 0.4% | 3 |
2 | ADV IMMUNOL | 3 | 32% | 1.0% | 8 |
3 | IMMUNOGENETHIGASHI KU | 2 | 50% | 0.4% | 3 |
4 | IMMUNOBIOL NEUROSCI | 2 | 11% | 2.0% | 15 |
5 | RAYMOND BEVERLY SACKLER GENET MOL MED | 2 | 22% | 0.8% | 6 |
6 | TRANSLAT PATHOLKITA KU | 1 | 100% | 0.3% | 2 |
7 | BIO IMAGING CELL DYNAM | 1 | 29% | 0.5% | 4 |
8 | VISUAL PROJECT | 1 | 24% | 0.5% | 4 |
9 | FOCAL ADHES BIOL GRP | 1 | 40% | 0.3% | 2 |
10 | PROV CELL MOL BIOL | 1 | 40% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000160313 | FOCAL ADHESION KINASE//FAK//PYK2 |
2 | 0.0000140303 | GRB2//SH2 DOMAIN//SH3 DOMAIN |
3 | 0.0000136671 | CBL B//CBL//CIN85 |
4 | 0.0000128974 | C ABL//BCR ABL//BCR ABL ONCOPROTEIN |
5 | 0.0000127285 | RAP1//EPAC//EPAC1 |
6 | 0.0000081283 | TIAM1//RHOB//RHOGDI2 |
7 | 0.0000061735 | PODOSOMES//INVADOPODIA//CORTACTIN |
8 | 0.0000061315 | VAV//VAV1//VAV3 |
9 | 0.0000059911 | PAK4//PAK1//P21 ACTIVATED KINASE |
10 | 0.0000052680 | MFG E8//APOPTOTIC CELLS//CELL CLEARANCE |